Patents by Inventor Andrea Klostermann

Andrea Klostermann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Kv1.3 potassium channel antagonists
    Patent number: 10800815
    Abstract: The present disclosure provides compounds that selectively bind and inhibit potassium channel Kv1.3.
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: October 13, 2020
    Assignee: Select ION Therapeutics GMBH
    Inventors: Andreas Klostermann, Jörg Stockhaus
  • Reduced Water Activity Date Composition
    Publication number: 20200178582
    Abstract: Described are food compositions that include a fruit paste, a dried fruit, and a nut butter. The food compositions have a lower water activity (less than 0.6) than similar fruit paste-based food compositions that do not include a dried fruit, while retaining a desired texture and moisture perception. Also described are methods of making the described food compositions, and food products including the described food compositions.
    Type: Application
    Filed: December 6, 2018
    Publication date: June 11, 2020
    Applicant: General Mills, Inc.
    Inventors: Jill A Conley, Jeffrey F Enz, Andrea Klostermann, Philippe A Vandweghe
  • KV1.3 POTASSIUM CHANNEL ANTAGONISTS
    Publication number: 20190375795
    Abstract: The present invention relates to compounds which are capable of selectively binding to and inhibiting the activity of the potassium channel Kv1.3. The invention also relates to pharmaceutical compositions comprising such compounds and to the use of said compounds and said pharmaceutical compositions for the treatment or prevention of autoimmune diseases, obesity, parodontitis and/or tissue transplant rejection.
    Type: Application
    Filed: February 21, 2019
    Publication date: December 12, 2019
    Inventors: Andreas Klostermann, Jörg Stockhaus
  • Kv1.3 potassium channel antagonists
    Patent number: 10370413
    Abstract: Compounds which selectively bind to and inhibit the activity of the potassium channel Kv1.3 are described. Pharmaceutical compositions comprising such compounds and the use of said compounds and said pharmaceutical compositions for the treatment or prevention of autoimmune diseases, obesity, parodontitis and/or tissue transplant rejection are also described.
    Type: Grant
    Filed: May 7, 2015
    Date of Patent: August 6, 2019
    Assignee: cgtx-Peptide Development GmbH
    Inventors: Andreas Klostermann, Jörg Stockhaus
  • Kv1.3 Potassium Channel Antagonists
    Publication number: 20170137470
    Abstract: The present invention relates to compounds which are capable of selectively binding to and inhibiting the activity of the potassium channel Kv1.3. The invention also relates to pharmaceutical compositions comprising such compounds and to the use of said compounds and said pharmaceutical compositions for the treatment or prevention of autoimmune diseases, obesity, parodontitis and/or tissue transplant rejection.
    Type: Application
    Filed: May 7, 2015
    Publication date: May 18, 2017
    Inventors: Andreas KLOSTERMANN, Jörg STOCKHAUS
  • Shelf-Stable, Brownie Product
    Publication number: 20150351413
    Abstract: A shelf stable, brownie product. The brownie avoids off tastes and staling, due to reducing the likelihood of recrystallization of sugars and oils, but managing the moisture in the brownie, the fat level, the protein level, and the level and type of sweetener used.
    Type: Application
    Filed: May 28, 2013
    Publication date: December 10, 2015
    Applicant: General Mills, Inc.
    Inventors: Jeffrey F Enz, Dana Dronen, Andrea Klostermann
  • Human semaphorin 6A-1 (SEMA6A-A), a gene involved in neuronal development and regeneration mechanisms during apoptosis, and its use as a potential drug target
    Patent number: 6900288
    Abstract: Human semaphorin 6A-1, a novel gene involved in neuronal development and regeneration mechanisms, is described.
    Type: Grant
    Filed: November 26, 1999
    Date of Patent: May 31, 2005
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
    Inventors: Christian Behl, Andreas Klostermann